Truist Financial started coverage on shares of Edgewise Therapeutics (NASDAQ:EWTX – Get Rating) in a research note published on Monday, The Fly reports. The brokerage issued a buy rating on the stock. Edgewise Therapeutics Price Performance Shares of NASDAQ EWTX opened at $9.53 on Monday. Edgewise Therapeutics has a 1 year low of $5.41 and […]